ADPT Adaptive Biotechnologies Corporation - Common Stock
NASDAQ · Life Sciences Tools & Services · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 4, 2026
$28.35
· % 处于52周区间
· 高于低点
· 至高点
$12.0052周低点
$29.9652周高点
市值 (MRQ)
$4.51B
P/E (TTM)
-70.9
EPS (TTM)
$-0.40
收入 (TTM)
$308M
ADPT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$28.35
市值 (MRQ)
$4.51B
P/E (TTM)
-70.9
EPS (TTM)
$-0.40
收入 (TTM)
$308M
ROE (TTM)
-39.6%
负债/权益 (MRQ)
0.0
52周区间
$12–$30
ADPT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Adaptive Biotechnologies Corporation - Common Stock 公司概况（来自维基百科）
行业板块Healthcare
行业Life Sciences Tools & Services
员工624
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$277M2017-12-31 → 2025-12-31
EPS$-0.392020-12-31 → 2025-12-31
自由现金流$-49M2019-12-31 → 2025-12-31
净利率-20.7%2019-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ADPT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -70.95年均值 ≈-14.9 | ≈-14.9 | · | · | |
| P/S (TTM) | 14.65年均值 ≈9.9 | ≈9.9 | 4.6 | 估值过高 | |
| 市净率 (MRQ) | 31.65年均值 ≈5.4 | ≈5.4 | 3.5 | 估值过高 | |
| EV / EBITDA (企业价值 / EBITDA) | -77.45年均值 ≈-18.1 | ≈-18.1 | · | · | |
| 股价/自由现金流 (TTM) | -187.65年均值 ≈-17.1 | ≈-17.1 | · | · | |
| 市现率 (TTM) | -214.65年均值 ≈-18.9 | ≈-18.9 | · | · | |
| EV / Revenue (市值/营收) | 16.05年均值 ≈6.4 | ≈6.4 | · | · | |
| EV / FCF (市值/自由现金流) | -90.35年均值 ≈-22.2 | ≈-22.2 | · | · | |
| 市净率（有形资产） (MRQ) | 31.75年均值 ≈10.4 | ≈10.4 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ADPT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -12.2%5年均值 ≈-97.6% | ≈-97.6% | 6.4% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -20.6%5年均值 ≈-97.6% | ≈-97.6% | 7.0% | 弱 | |
| Pretax Margin (税前利润率) | -21.5%5年均值 ≈-97.1% | ≈-97.1% | 5.9% | 弱 | |
| 净利润率 (TTM) | -20.7%5年均值 ≈-97.0% | ≈-97.0% | 2.4% | 弱 | |
| ROA (TTM) | -11.2%5年均值 ≈-22.1% | ≈-22.1% | -0.64% | 弱 | |
| ROE (TTM) | -39.6%5年均值 ≈-43.4% | ≈-43.4% | -0.84% | 弱 | |
| ROIC | -16.3% | · | -1.8% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ADPT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.05年均值 ≈0.6 | ≈0.6 | 0.7 | 低负债 | |
| 流动比率 (MRQ) | 4.85年均值 ≈3.9 | ≈3.9 | 3.0 | 流动性强 | |
| Quick Ratio (速动比率) | 1.35年均值 ≈1.2 | ≈1.2 | 2.2 | 流动性强 | |
| 长期负债/股东权益 (MRQ) | 0.05年均值 ≈0.6 | ≈0.6 | 0.7 | 低负债 | |
| Interest Coverage (利息保障倍数) | -4.85年均值 ≈-20.6 | ≈-20.6 | 3.7 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ADPT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 54.8%5年均值 ≈25.7% | ≈25.7% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 14.3%5年均值 ≈13.2% | ≈13.2% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 23.0% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ADPT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.55年均值 ≈0.3 | ≈0.3 | 0.5 | 持平 | |
| Inventory Turnover (库存周转率) | 7.85年均值 ≈5.1 | ≈5.1 | 4.0 | 顶尖 | |
| Receivables Turnover (应收账款周转率) | 6.05年均值 ≈6.5 | ≈6.5 | 6.2 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$443.9K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
51.3%
下次报告
十一月 03, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 3, 2026 | $-0.10 | $-0.14 | 26.7% |
| 2026年3月31日 | $-0.12 | $-0.16 | 26.5% | |
| 2025年12月31日 | $-0.09 | $-0.18 | 51.3% | |
| 2025年9月30日 | $0.06 | $-0.15 | 140.2% | |
| 2025年6月30日 | $-0.17 | $-0.24 | 30.2% | |
| 2025年3月31日 | $-0.20 | $-0.30 | 33.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $277M | $179M | $170M | $185M | $154M | $98M | $85M | $56M | |
| Cost of Revenue | $71M | $72M | $76M | $58M | $49M | $23M | $22M | $20M | |
| R&D Expense | $94M | $103M | $122M | $142M | $142M | $116M | $71M | $39M | |
| SG&A Expense | $73M | $73M | $84M | $89M | $75M | $50M | $30M | $20M | |
| Operating Expenses | $334M | $342M | $397M | $385M | $363M | $251M | $163M | $105M | |
| Operating Income | $-57M | $-163M | $-227M | $-200M | $-209M | $-153M | $-78M | $-50M | |
| Interest Expense | $12M | $12M | $14M | $4M | · | · | · | · | |
| Pretax Income | $-59M | $-160M | $-225M | $-200M | $-207M | $-146M | $-69M | · | |
| Income Tax | $0 | $0 | $0 | · | · | · | $0 | · | |
| Net Income | $-59M | $-159M | $-225M | $-200M | $-207M | $-146M | $-69M | $-46M | |
| EPS (Basic) | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 | $-1.11 | · | · | |
| EPS (Diluted) | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 | $-1.11 | · | · | |
| Shares (Basic) | 151,721,939 | 147,101,648 | 144,383,294 | 142,515,917 | 140,354,915 | 131,216,468 | · | · | |
| Shares (Diluted) | 151,721,939 | 147,101,648 | 144,383,294 | 142,515,917 | 140,354,915 | 131,216,468 | · | · | |
| EBITDA | $-57M | $-163M | $-227M | $-200M | $-209M | $-153M | $-78M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70M | $48M | $65M | $90M | $139M | $123M | $97M | $55M | |
| Receivables | $50M | $42M | $38M | $40M | $17M | $10M | $13M | $5M | |
| Inventory | $10M | $8M | $14M | $14M | $19M | $14M | $9M | $8M | |
| Prepaid Expense | $13M | $11M | $11M | $9M | $13M | $15M | $14M | $3M | |
| Current Assets | $300M | $284M | $410M | $562M | $403M | $727M | $613M | $181M | |
| PP&E (Net) | $34M | $49M | $68M | $83M | $85M | $40M | $60M | $19M | |
| PP&E (Gross) | $130M | $136M | $141M | $138M | $121M | $64M | $78M | $32M | |
| Accum. Depreciation | $96M | $88M | $73M | $54M | $36M | $24M | $18M | $12M | |
| Goodwill | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | |
| Intangibles | $2M | $3M | $5M | $7M | $9M | $10M | $12M | $14M | |
| Other Non-current Assets | $1M | $2M | $4M | $2M | $875.0K | $598.0K | $784.0K | $186.0K | |
| Total Assets | $513M | $539M | $661M | $857M | $923M | $1.12B | $912M | $333M | |
| Accounts Payable | $6M | $7M | $8M | $8M | $3M | $3M | $4M | $2M | |
| Accrued Liabilities | $8M | $8M | $9M | $12M | $9M | $13M | $4M | $3M | |
| Current Liabilities | $90M | $98M | $88M | $110M | $114M | $105M | $78M | $23M | |
| Capital Leases | $70M | $79M | $89M | $99M | $107M | $104M | · | · | |
| Other Non-current Liabilities | $20.0K | $20.0K | · | · | · | · | $93.0K | · | |
| Total Liabilities | $288M | $337M | $353M | $393M | $319M | $373M | $341M | $30M | |
| Long-term Debt | $131M | $133M | · | · | · | · | · | · | |
| Total Debt | $131M | $133M | $131M | · | · | · | · | · | |
| Common Stock | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $1.0K | |
| Paid-in Capital | $1.58B | $1.51B | $1.45B | $1.39B | $1.32B | $1.25B | $936M | $38M | |
| Retained Earnings | $-1.36B | $-1.30B | $-1.14B | $-919M | $-719M | $-512M | $-365M | $-296M | |
| AOCI | $253.0K | $166.0K | $215.0K | $-4M | $-1M | $893.0K | $671.0K | $-107.0K | |
| Stockholders' Equity | $219M | $203M | $308M | $464M | $604M | $743M | $571M | $-258M | |
| Liabilities + Equity | $513M | $539M | $661M | $857M | $923M | $1.12B | $912M | $333M | |
| Shares Outstanding | 153,779,418 | 147,773,744 | 145,082,271 | 143,105,002 | 141,393,865 | 137,646,896 | 125,238,142 | 12,841,536 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $17M | $20M | $21M | · | · | · | · | |
| Stock-based Comp | $51M | $54M | $63M | $55M | $43M | $25M | $13M | $11M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | $2M | · | $2M | · | · | · | · | |
| Operating Cash Flow | $-46M | $-95M | $-156M | $-184M | $-193M | $-150M | $205M | $-32M | |
| CapEx | $3M | $4M | $11M | $16M | $62M | $19M | $11M | $6M | |
| Investing Cash Flow | $38M | $78M | $130M | $3M | $181M | $-117M | $-482M | $736.0K | |
| Stock Issued | · | · | · | · | · | $272M | $321M | · | |
| Net Stock Activity | · | · | · | · | · | $272M | · | · | |
| Financing Cash Flow | $30M | $241.0K | $2M | $132M | $27M | $294M | $320M | $1M | |
| Net Change in Cash | $22M | $-17M | $-24M | $-49M | $16M | $27M | $44M | $-30M | |
| Free Cash Flow | $-49M | $-99M | $-167M | $-200M | $-254M | $-168M | $194M | · | |
| Levered FCF | $-61M | · | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% | -155.3% | -92.2% | · | |
| Net Margin | -21.5% | -89.1% | -132.3% | -108.0% | -134.3% | -148.6% | -80.7% | · | |
| Pretax Margin | -21.5% | -89.2% | -132.3% | -108.1% | -134.3% | · | · | · | |
| EBITDA Margin | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% | -155.3% | -92.2% | · | |
| ROA | -11.3% | -26.6% | -29.7% | -22.5% | -20.3% | -14.4% | -11.0% | · | |
| ROE | -28.2% | -62.4% | -58.3% | -37.5% | -30.8% | -23.0% | -11.9% | · | |
| ROIC | -16.3% | · | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.9 | 4.7 | 5.1 | 3.5 | 6.9 | 7.8 | · | |
| Quick Ratio | 1.3 | 0.9 | 1.2 | 1.2 | 1.4 | 1.3 | 1.4 | · | |
| Debt / Equity | 0.6 | 0.7 | 0.4 | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 0.4 | · | · | · | · | · | |
| Interest Coverage | -4.8 | -14.0 | -16.5 | -47.2 | · | · | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | · | |
| Inventory Turnover | 7.8 | 6.3 | 5.2 | 3.4 | 3.0 | 1.9 | 2.6 | · | |
| Receivables Turnover | 6.0 | 4.5 | 4.4 | 6.4 | 11.2 | 8.7 | 9.7 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.42 | $1.37 | $2.13 | $3.24 | $4.27 | $5.40 | $4.56 | · | |
| Revenue / Share | $1.83 | $1.22 | $1.18 | $1.30 | · | · | · | · | |
| Cash Flow / Share | $-0.30 | $-0.65 | $-1.08 | $-1.29 | · | · | · | · | |
| Cash / Share | $0.46 | $0.32 | $0.45 | $0.63 | $0.98 | $0.90 | $0.77 | · | |
| EPS (TTM) | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 | $-1.11 | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 54.8% | 5.1% | -8.1% | 20.1% | 56.9% | · | · | · | |
| Revenue CAGR 3Y | 14.3% | 5.1% | 20.1% | · | · | · | · | · | |
| Revenue CAGR 5Y | 23.0% | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277M | $179M | $170M | $185M | $154M | $98M | $85M | · | |
| Net Income TTM | $-59M | $-159M | $-225M | $-200M | $-207M | $-146M | $-69M | · | |
| Market Cap | $2.50B | $886M | $711M | $1.09B | $3.97B | $8.14B | $3.75B | · | |
| Enterprise Value | $2.56B | $971M | $776M | · | · | · | · | · | |
| P/E | -41.6 | -5.6 | -3.1 | -5.5 | -19.0 | -53.3 | · | · | |
| P/S | 9.0 | 5.0 | 4.2 | 5.9 | 25.7 | 82.7 | 44.0 | · | |
| P/B | 11.4 | 4.4 | 2.3 | 2.4 | 6.6 | 11.0 | 6.6 | · | |
| P / Tangible Book | 25.5 | 11.0 | 3.9 | 3.2 | 8.3 | 13.3 | · | · | |
| P / Cash Flow | -54.3 | -9.3 | -4.5 | -5.9 | -20.6 | -54.4 | 18.2 | · | |
| P / FCF | -51.0 | -9.0 | -4.3 | -5.5 | -15.6 | -48.3 | 19.3 | · | |
| EV / EBITDA | -44.8 | -6.0 | -3.4 | · | · | · | · | · | |
| EV / FCF | -52.3 | -9.8 | -4.6 | · | · | · | · | · | |
| EV / Revenue | 9.2 | 5.4 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -2.4% | -18.0% | -31.8% | -18.3% | -5.3% | -1.9% | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $71M | $72M | $94M | $59M | $52M | $47M | $46M | $43M | $42M | $46M | $38M | $49M | $38M | $48M | $44M | |
| Cost of Revenue | $20M | $19M | $18M | $18M | $18M | $17M | $18M | $17M | $19M | $18M | $20M | $19M | $18M | $19M | $15M | $13M | |
| R&D Expense | $19M | $24M | $22M | $24M | $24M | $24M | $23M | $24M | $25M | $30M | $29M | $29M | $32M | $33M | $36M | $37M | |
| SG&A Expense | $21M | $21M | $20M | $18M | $18M | $17M | $18M | $17M | $18M | $20M | $21M | $20M | $22M | $21M | $21M | $21M | |
| Operating Expenses | $87M | $90M | $84M | $84M | $84M | $82M | $81M | $79M | $91M | $91M | $117M | $89M | $97M | $95M | $93M | $96M | |
| Operating Income | $-16M | $-19M | $-13M | $10M | $-25M | $-30M | $-34M | $-33M | $-47M | $-49M | $-71M | $-51M | $-48M | $-57M | $-45M | $-53M | |
| Interest Expense | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $653.0K | · | |
| Net Income | $-40M | $-20M | $-14M | $10M | $-26M | $-30M | $-34M | $-32M | $-46M | $-48M | $-69M | $-50M | $-48M | $-58M | $-45M | $-52M | |
| EPS (Basic) | $-0.25 | $-0.13 | $-0.08 | $0.06 | $-0.17 | $-0.20 | $-0.22 | $-0.22 | $-0.31 | $-0.33 | $-0.48 | $-0.35 | $-0.33 | $-0.40 | $-0.32 | $-0.37 | |
| EPS (Diluted) | $-0.25 | $-0.13 | $-0.08 | $0.06 | $-0.17 | $-0.20 | $-0.22 | $-0.22 | $-0.31 | $-0.33 | $-0.48 | $-0.35 | $-0.33 | $-0.40 | $-0.32 | $-0.37 | |
| Shares (Basic) | 159,855,257 | 155,521,048 | · | 152,432,307 | 152,082,284 | 149,195,028 | · | 147,516,398 | 147,414,095 | 145,787,527 | · | 144,704,868 | 144,397,693 | 143,511,142 | 142,928,654 | 142,363,589 | |
| Shares (Diluted) | 159,855,257 | 155,521,048 | · | 163,162,107 | 152,082,284 | 149,195,028 | · | 147,516,398 | 147,414,095 | 145,787,527 | · | 144,704,868 | 144,397,693 | 143,511,142 | 142,928,654 | 142,363,589 | |
| EBITDA | $-16M | $-19M | · | $10M | $-25M | $-30M | · | $-33M | $-47M | $-49M | · | $-51M | $-48M | $-57M | $-45M | $-53M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $170M | $78M | $70M | $55M | $43M | $51M | $48M | $38M | $60M | $71M | · | $89M | $109M | $95M | $218M | $76M | |
| Receivables | $50M | $48M | $50M | $45M | $44M | $44M | $42M | $41M | $36M | $42M | · | $31M | $32M | $31M | $27M | $24M | |
| Inventory | $10M | $11M | $10M | $10M | $8M | $9M | $8M | $12M | $13M | $13M | · | $19M | $19M | $20M | $17M | $19M | |
| Prepaid Expense | $16M | $14M | $13M | $14M | $11M | $11M | $11M | $12M | $11M | $10M | · | $13M | $9M | $10M | $12M | $12M | |
| Current Assets | $421M | $292M | $300M | $281M | $262M | $256M | $284M | $308M | $352M | $374M | · | $435M | $477M | $501M | $564M | $439M | |
| PP&E (Net) | $29M | $31M | $34M | $37M | $41M | $44M | $49M | $51M | $55M | $65M | · | $77M | $79M | $81M | $87M | $87M | |
| PP&E (Gross) | · | · | $130M | · | · | · | $136M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $96M | · | · | · | $88M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | · | $119M | $119M | $119M | $119M | $119M | |
| Intangibles | $884.0K | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $5M | · | $6M | $6M | $6M | $7M | $8M | |
| Other Non-current Assets | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | · | $3M | $3M | $2M | $2M | $778.0K | |
| Total Assets | $641M | $506M | $513M | $491M | $497M | $511M | $539M | $559M | $585M | $620M | · | $718M | $765M | $791M | $884M | $807M | |
| Accounts Payable | $5M | $10M | $6M | $10M | $7M | $6M | $7M | $7M | $10M | $12M | · | $4M | $9M | $6M | $4M | $3M | |
| Accrued Liabilities | $11M | $7M | $8M | $7M | $7M | $8M | $8M | $6M | $7M | $8M | · | $10M | $8M | $8M | $11M | $9M | |
| Current Liabilities | $88M | $87M | $90M | $83M | $92M | $88M | $98M | $88M | $88M | $83M | · | $93M | $95M | $90M | $104M | $111M | |
| Capital Leases | $67M | $69M | $70M | $72M | $74M | $76M | $79M | $82M | $84M | $87M | · | $92M | $94M | $96M | $101M | $103M | |
| Other Non-current Liabilities | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $490M | $282M | $288M | $286M | $317M | $321M | $337M | $335M | $343M | $346M | · | $356M | $369M | $368M | $396M | $288M | |
| Long-term Debt | $0 | $131M | $131M | $132M | $134M | $134M | $133M | · | · | · | · | $130M | · | · | · | · | |
| Total Debt | $0 | $131M | · | $132M | $134M | $134M | · | $133M | $132M | $132M | · | $130M | · | · | · | · | |
| Common Stock | $16.0K | $16.0K | $15.0K | $15.0K | $15.0K | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | · | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | |
| Paid-in Capital | $1.57B | $1.60B | $1.58B | $1.55B | $1.54B | $1.52B | $1.51B | $1.49B | $1.48B | $1.47B | · | $1.44B | $1.42B | $1.40B | $1.37B | $1.36B | |
| Retained Earnings | $-1.42B | $-1.38B | $-1.36B | $-1.35B | $-1.36B | $-1.33B | $-1.30B | $-1.27B | $-1.24B | $-1.19B | · | $-1.07B | $-1.02B | $-977M | $-879M | $-834M | |
| AOCI | $-212.0K | $-28.0K | $253.0K | $211.0K | $73.0K | $134.0K | $166.0K | $497.0K | $-182.0K | $-106.0K | · | $-250.0K | $-893.0K | $-2M | $-6M | $-6M | |
| Stockholders' Equity | $143M | $216M | $219M | $204M | $180M | $190M | $203M | $224M | $242M | $275M | · | $362M | $396M | $424M | $488M | $518M | |
| Liabilities + Equity | $641M | $506M | $513M | $491M | $497M | $511M | $539M | $559M | $585M | $620M | · | $718M | $765M | $791M | $884M | $807M | |
| Shares Outstanding | 159,059,622 | 159,697,221 | 153,779,418 | 152,581,042 | 152,234,772 | 151,916,722 | 147,773,744 | 147,561,586 | 147,462,201 | 147,368,324 | · | 144,772,751 | 144,645,118 | 144,279,969 | 142,987,127 | 142,784,868 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $3M | $6M | $6M | $5M | · | · | |
| Stock-based Comp | $11M | $12M | $13M | $13M | $13M | $12M | $13M | $14M | $13M | $14M | $16M | $15M | $17M | $15M | $14M | $14M | |
| Amort. of Intangibles | $423.0K | $419.0K | $429.0K | $428.0K | $423.0K | $419.0K | $428.0K | $428.0K | $424.0K | $423.0K | $429.0K | $428.0K | $423.0K | $419.0K | $428.0K | $423.0K | |
| Restructuring | · | $643.0K | · | · | · | $0 | $87.0K | $193.0K | $680.0K | $1M | · | · | · | · | · | · | |
| Operating Cash Flow | $-6M | $-10M | $2M | $-7M | $-12M | $-28M | $-12M | $-27M | $-17M | $-38M | $-27M | $-47M | $-24M | $-59M | $-42M | $-47M | |
| CapEx | $1M | $796.0K | $636.0K | $409.0K | $655.0K | $1M | $80.0K | $344.0K | $2M | $2M | $1M | $3M | $4M | $3M | $5M | $5M | |
| Investing Cash Flow | $-43M | $9M | $-8M | $17M | $3M | $26M | $22M | $5M | $6M | $45M | $3M | $26M | $37M | $63M | $58M | $5M | |
| Financing Cash Flow | $142M | $8M | $22M | $2M | $2M | $5M | $127.0K | $40.0K | $30.0K | $44.0K | $87.0K | $17.0K | $1M | $672.0K | $126M | $4M | |
| Net Change in Cash | $92M | $7M | $15M | $12M | $-7M | $3M | $10M | $-22M | $-11M | $6M | $-24M | $-21M | $15M | $4M | $141M | $-38M | |
| Free Cash Flow | · | $-10M | · | · | · | $-30M | · | · | · | $-40M | · | · | · | $-62M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -22.0% | -27.1% | · | 10.9% | -42.5% | -56.5% | · | -70.3% | -109.6% | -116.5% | · | -134.4% | -97.7% | -151.9% | -95.0% | -120.2% | |
| Net Margin | -55.6% | -28.3% | · | 10.2% | -43.5% | -56.9% | · | -69.1% | -107.0% | -113.5% | · | -132.7% | -97.7% | -153.3% | -94.7% | -119.2% | |
| EBITDA Margin | -22.0% | -27.1% | · | 10.9% | -42.5% | -56.5% | · | -70.3% | -109.6% | -116.5% | · | -134.4% | -97.7% | -151.9% | -95.0% | -120.2% | |
| ROA | -7.0% | -3.9% | · | 1.8% | -4.7% | -5.3% | · | -5.0% | -6.9% | -6.7% | · | -6.3% | -6.1% | -7.0% | -4.8% | -5.7% | |
| ROE | -24.7% | -9.8% | · | 4.5% | -12.2% | -12.8% | · | -10.9% | -14.5% | -13.6% | · | -11.8% | -10.5% | -11.8% | -8.0% | -8.6% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | 3.4 | · | 3.4 | 2.8 | 2.9 | · | 3.5 | 4.0 | 4.5 | · | 4.7 | 5.0 | 5.6 | 5.4 | 3.9 | |
| Quick Ratio | 2.5 | 1.4 | · | 1.2 | 0.9 | 1.1 | · | 0.9 | 1.1 | 1.4 | · | 1.3 | 1.5 | 1.4 | 2.3 | 0.9 | |
| Debt / Equity | 0.0 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | · | · | · | · | |
| LT Debt / Equity | 0.0 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | · | · | · | · | |
| Interest Coverage | -5.9 | -6.6 | · | 3.5 | -8.5 | -10.2 | · | -11.1 | -17.6 | -16.3 | · | -14.0 | -13.3 | -16.2 | -69.6 | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | |
| Inventory Turnover | 2.1 | 1.9 | · | 1.7 | 1.7 | 1.5 | · | 1.1 | 1.2 | 1.1 | · | 1.1 | 0.9 | 0.9 | 0.8 | 0.7 | |
| Receivables Turnover | 1.5 | 1.5 | · | 2.2 | 1.5 | 1.2 | · | 1.3 | 1.3 | 1.1 | · | 1.3 | 1.8 | 1.4 | 2.2 | 2.3 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.90 | $1.35 | · | $1.34 | $1.18 | $1.25 | · | $1.52 | $1.64 | $1.87 | · | $2.50 | $2.74 | $2.94 | $3.41 | $3.63 | |
| Revenue / Share | $0.45 | $0.46 | · | $0.58 | $0.39 | $0.35 | · | $0.31 | $0.29 | $0.29 | · | $0.26 | $0.34 | $0.26 | $0.33 | $0.31 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.19 | · | · | · | $-0.26 | · | · | · | $-0.41 | · | · | |
| Cash / Share | $1.07 | $0.49 | · | $0.36 | $0.28 | $0.33 | · | $0.26 | $0.41 | $0.48 | · | $0.61 | $0.76 | $0.66 | $1.52 | $0.54 | |
| EPS (TTM) | $-0.40 | $-0.32 | · | $-0.53 | $-0.81 | $-0.95 | · | $-1.34 | $-1.47 | $-1.49 | · | $-1.35 | $-1.32 | $-1.36 | $-1.57 | $-1.65 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $308M | $295M | · | $253M | $205M | $190M | · | $177M | $169M | $175M | · | $180M | $190M | $184M | $168M | $160M | |
| Net Income TTM | $-64M | $-50M | · | $-80M | $-121M | $-142M | · | $-195M | $-213M | $-215M | · | $-196M | $-191M | $-195M | $-221M | $-232M | |
| Market Cap | $3.41B | $2.22B | · | $2.28B | $1.77B | $1.13B | · | $756M | $534M | $473M | · | $789M | $971M | $1.27B | $1.02B | $1.16B | |
| Enterprise Value | $3.24B | $2.27B | · | $2.36B | $1.86B | $1.21B | · | $850M | $606M | $533M | · | $830M | · | · | · | · | |
| P/E | -53.6 | -43.4 | · | -28.2 | -14.4 | -7.8 | · | -3.8 | -2.5 | -2.2 | · | -4.0 | -5.1 | -6.5 | -4.5 | -4.9 | |
| P/S | 11.1 | 7.5 | · | 9.0 | 8.6 | 6.0 | · | 4.3 | 3.2 | 2.7 | · | 4.4 | 5.1 | 6.9 | 6.1 | 7.2 | |
| P/B | 23.9 | 10.2 | · | 11.2 | 9.9 | 5.9 | · | 3.4 | 2.2 | 1.7 | · | 2.2 | 2.5 | 3.0 | 2.1 | 2.2 | |
| P / Tangible Book | 148.0 | 23.1 | · | 27.4 | 30.5 | 16.5 | · | 7.5 | 4.5 | 3.1 | · | 3.3 | 3.6 | 4.3 | 2.8 | 2.9 | |
| P / Cash Flow | · | -232.4 | · | · | · | -39.6 | · | · | · | -12.3 | · | · | · | -21.5 | · | · | |
| EV / Revenue | 10.5 | 7.7 | · | 9.3 | 9.1 | 6.4 | · | 4.8 | 3.6 | 3.1 | · | 4.6 | · | · | · | · | |
| Earnings Yield | -1.9% | -2.3% | · | -3.5% | -7.0% | -12.8% | · | -26.2% | -40.6% | -46.4% | · | -24.8% | -19.7% | -15.4% | -22.1% | -20.4% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $277M | $179M | $170M | $185M | $154M |
| 营业利润率 % | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% |
| 净收入 | $-59M | $-159M | $-225M | $-200M | $-207M |
| 稀释后每股收益 (EPS) | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.6 | 0.7 | 0.4 | · | · |
| 流动比率 | 3.3 | 2.9 | 4.7 | 5.1 | 3.5 |
| 速动比率 | 1.3 | 0.9 | 1.2 | 1.2 | 1.4 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-49M | $-99M | $-167M | $-200M | $-254M |
机构持有人 (13F) 312 家申报者 · $3.5B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
312
持有价值
$3.5B
新仓位
46
已退出持仓
37
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 46 (-11 与上一季度对比) | 37 (0 与上一季度对比) | 113 (+14 与上一季度对比) | 85 (-12 与上一季度对比) | +17.2M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | $643365037 | 29993708 | 18.50% | 股份 |
| BlackRock, Inc. | $324734962 | 15139159 | 9.34% | 股份 |
| VANGUARD GROUP INC | $183222148 | 11282152 | 5.27% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $137356941 | 6403587 | 3.95% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $126798802 | 5911366 | 3.65% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117465155 | 5476231 | 3.38% | 股份 |
| D. E. Shaw & Co., Inc. | $99224675 | 4625859 | 2.85% | 股份 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $91540985 | 4267645 | 2.63% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $78131203 | 3641837 | 2.25% | 股份 |
| STATE STREET CORP | $74181636 | 3458388 | 2.13% | 股份 |
| Invesco Ltd. | $66366535 | 3094011 | 1.91% | 股份 |
| GOLDMAN SACHS GROUP INC | $64011670 | 2984227 | 1.84% | 股份 |
| UBS Group AG | $61392474 | 2862120 | 1.77% | 买入期权 |
| Driehaus Capital Management LLC | $54219229 | 2527703 | 1.56% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $54153099 | 2524620 | 1.56% | 股份 |
| Nuveen, LLC | $50754025 | 2366155 | 1.46% | 股份 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $46810892 | 2182326 | 1.35% | 股份 |
| FRED ALGER MANAGEMENT, LLC | $44879492 | 2092284 | 1.29% | 股份 |
| ARK Investment Management LLC | $44837058 | 2090306 | 1.29% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $42284385 | 1971300 | 1.22% | 买入期权 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $40523000 | 1889188 | 1.17% | 股份 |
| Aristotle Atlantic Partners, LLC | $39436104 | 1838513 | 1.13% | 股份 |
| TORONTO DOMINION BANK | $38610000 | 1800000 | 1.11% | 买入期权 |
| BANK OF AMERICA CORP /DE/ | $37109444 | 1730044 | 1.07% | 股份 |
| JANE STREET GROUP, LLC | $34116504 | 1590513 | 0.98% | 股份 |
| NORTHERN TRUST CORP | $32332679 | 1507351 | 0.93% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $28525411 | 1329856 | 0.82% | 股份 |
| Amova Asset Management Americas, Inc. | $28512113 | 1329856 | 0.82% | 股份 |
| OBERWEIS ASSET MANAGEMENT INC/ | $27000209 | 1258751 | 0.78% | 股份 |
| PERCEPTIVE ADVISORS LLC | $26111621 | 1217325 | 0.75% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25279940 | 1178552 | 0.73% | 股份 |
| AMERIPRISE FINANCIAL INC | $23332376 | 1087754 | 0.67% | 股份 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $22993006 | 1071935 | 0.66% | 股份 |
| Blue Water Life Science Advisors, LP | $21667610 | 1010145 | 0.62% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $20049508 | 934709 | 0.58% | 股份 |
| Aberdeen Group plc | $19712507 | 918998 | 0.57% | 股份 |
| Freestone Grove Partners LP | $18912208 | 881688 | 0.54% | 股份 |
| KENNEDY CAPITAL MANAGEMENT LLC | $18228103 | 849795 | 0.52% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $16857619 | 785903 | 0.48% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $16679842 | 777615 | 0.48% | 股份 |
| MORGAN STANLEY | $16435667 | 766230 | 0.47% | 股份 |
| Granite Investment Partners, LLC | $16242305 | 757217 | 0.47% | 股份 |
| Trexquant Investment LP | $15792777 | 736260 | 0.45% | 股份 |
| FMR LLC | $15219503 | 709534 | 0.44% | 股份 |
| JENNISON ASSOCIATES LLC | $14718882 | 686195 | 0.42% | 股份 |
| Hillsdale Investment Management Inc. | $14676454 | 684217 | 0.42% | 股份 |
| NEXT CENTURY GROWTH INVESTORS LLC | $13080853 | 609830 | 0.38% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $11657753 | 543485 | 0.34% | 股份 |
| ExodusPoint Capital Management, LP | $11114232 | 518146 | 0.32% | 股份 |
| SEI INVESTMENTS CO | $10935157 | 509797 | 0.31% | 股份 |
公司内部人士 27 位内幕人士 · 17 位高管 · 10 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Chad M Robins | CEO and Chairman | 2026年8月18日 M | 2180518 | 0 | 19 | $-39801326 |
| Kyle Piskel | Chief Financial Officer | 2026年5月18日 S | 256725 | 0 | 6 | $-3581681 |
| Tycho Peterson | Chief Financial Officer | 2024年3月5日 S | 531553 | 0 | 0 | $0 |
| Chad M Cohen | Chief Financial Officer | 2021年12月22日 M | 21604 | 0 | 0 | $0 |
| Julie Rubinstein | President and COO | 2026年4月27日 M | 377802 | 0 | 47 | $-13371115 |
| Mark R Adams | Chief Operating Officer | 2023年4月11日 S | 175361 | 0 | 0 | $0 |
| Francis Lo | Chief People Officer | 2026年9月16日 M | 220867 | 0 | 15 | $-13213683 |
| Susan Bobulsky | Chief Commercial Officer, MRD | 2026年9月15日 S | 395794 | 0 | 9 | $-1204076 |
| Harlan S Robins | Chief Scientific Officer | 2026年7月21日 M | 812058 | 0 | 17 | $-29647952 |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | 2026年6月29日 M | 221278 | 0 | 6 | $-14690980 |
| Stacy L Taylor | SVP and General Counsel | 2024年8月22日 S | 139365 | 0 | 0 | $0 |
| Nitin Sood | Chief Commercial Officer, MRD | 2023年8月8日 S | 214808 | 0 | 0 | $0 |
| Lance Baldo | Chief Medical Officer | 2022年3月8日 S | 17171 | 0 | 0 | $0 |
| Jyoti Palaniappan | SVP, Diagnostics, T-Detect | 2021年7月19日 M | 9158 | 0 | 0 | $0 |
| Henning Thorsen | SVP, Commercial Operations | 2021年5月17日 A | 29061 | 0 | 0 | $0 |
| Nancy Louise Hill | EVP, Operations & Program Mana | 2021年1月19日 M | 10000 | 0 | 0 | $0 |
| Charles Sang | SVP, External Affairs | 2020年12月11日 M | 0 | 0 | 0 | $0 |
| Katey Einterz Owen | 董事 | 2026年8月31日 G | 66100 | 0 | 1 | $-249990 |
| Robert Hershberg | 董事 | 2026年8月18日 M | 46683 | 0 | 3 | $-1115696 |
| Peter M Neupert | 董事 | 2026年8月17日 M | 130625 | 0 | 3 | $-3135850 |
| Michelle Renee Griffin | 董事 | 2026年6月25日 M | 15625 | 0 | 3 | $-2000259 |
| Michael J Pellini | 董事 | 2025年3月4日 A | 69690 | 0 | 0 | $0 |
| Kevin T Conroy | 董事 | 2023年3月6日 A | 22968 | 0 | 0 | $0 |
| Leslie Trigg | 董事 | 2023年3月6日 A | 25907 | 0 | 0 | $0 |
| David E. Goel | 董事 | 2021年2月15日 A | 1504 | 0 | 0 | $0 |
| Andris A Zoltners | 董事 | 2020年2月13日 A | 3621016 | 0 | 0 | $0 |
| Eric Dobmeier | · | 2021年2月14日 A | 1504 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 35 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2.57% | 1774756 NS | 2026年7月31日 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2.11% | 64619 NS | 2026年7月31日 | N-PORT |
| MEDI · Harbor ETF Trust | 0.98% | 17855 NS | 2026年7月31日 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trus... | 0.96% | 135356 SH | 2026年10月1日 | 每日 |
| BRNY · EA Series Trust | 0.57% | 147197 NS | 2026年7月31日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.57% | 327285 NS | 2026年7月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.30% | 11293 SH | 2026年10月1日 | 每日 |
| IBB · iShares Trust | 0.28% | 1179205 SH | 2026年9月11日 | 每日 |
| FYX · First Trust Exchange-Traded Alpha... | 0.27% | 162673 NS | 2026年7月31日 | N-PORT |
| IWO · iShares Trust | 0.24% | 1444121 SH | 2026年9月11日 | 每日 |
| ESSC · Strategy Shares | 0.24% | 3763 NS | 2026年7月31日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.19% | 165252 SH | 2026年8月19日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.14% | 42053 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.12% | 49206 SH | 2026年9月11日 | 每日 |
| IWM · iShares Trust | 0.12% | 3941006 SH | 2026年9月11日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.12% | 29650 NS | 2026年7月31日 | N-PORT |
| RSSL · Global X Funds | 0.11% | 73784 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.10% | 886884 SH | 2026年8月19日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.09% | 86935 SH | 2026年10月1日 | 每日 |
| ESML · iShares Trust | 0.06% | 69841 SH | 2026年9月11日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.06% | 51690 SH | 2026年8月19日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | 0.04% | 1011327 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.04% | 345932 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 55701 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 1415247 SH | 2026年8月19日 | 每日 |
| WSML · iShares Trust | 0.03% | 7584 SH | 2026年9月11日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.02% | 1746783 SH | 2026年8月19日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.01% | 1197 SH | 2026年10月1日 | 每日 |
| TILT · FlexShares Trust | 0.01% | 9559 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.01% | 43739 SH | 2026年9月10日 | 每日 |
| ITOT · iShares Trust | 0.00% | 170690 SH | 2026年9月11日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4835465 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 12307 SH | 2026年8月19日 | 每日 |
| ISCB · iShares Trust | · | 6963 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 172353 SH | 2026年9月11日 | 每日 |
ADPT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 14 位分析师
买入
中位数目标
$27.25
-3.9%
5 35.7%
强烈买入
7 50.0%
买入
2 14.3%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
8 位分析师 · 2026-09-30平均目标 $27.44 -3.2%
现在
当前价格 $28.35
最低$21.00
平均值$27.44
最高$35.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | · |
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | · |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| BIO | · | · | · | · | · | · |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ALMR | · | · | · | · | · | · |
| MRVI | · | -3.6 | -28.3% | -70.4% | -48.6% | 18.3% |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | · |
| BLFS | · | -241.8 | 28.9% | · | · | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 4, 2026 申报